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Green Fluorescent Protein: is seeing believing and is that enough? 
Abstract:  
Intracellular compartmentalisation is a significant barrier to the successful nucleocytosolic delivery of biologics. 
The endocytic system has been shown to be responsible for compartmentalisation, providing an entry point, and 
trigger(s) for the activation of drug delivery systems. Consequently, many of the technologies used to understand 
endocytosis have found utility within the field of drug delivery. The use of fluorescent proteins as markers 
denoting compartmentalisation within the endocytic system has become commonplace. Several of the limitations 
associated with the use of green fluorescent protein (GFP) within the context of drug delivery have been 
explored here by asking a series of related questions: (1) Are molecules that regulate fusion to a specific 
compartment (i.e. Rab- or SNARE-GFP fusions) a good choice of marker for that compartment? (2) How 
reliable was GFP-marker overexpression when used to define a given endocytic compartment?  (3) Can 
glutathione-s-transferase (GST) fused in frame with GFP (GST-GFP) act as a fluid phase endocytic probe? (4) 
Was GFP fluorescence a robust indicator of (GFP) protein integrity? This study concluded that there are many 
appropriate and useful applications for GFP; however, thought and an understanding of the biological and 
physicochemical character of these markers are required for the generation of meaningful data. 
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Introduction.  
The scientific method requires the iterative gathering and interpretation of 
evidence used to test a hypothesis (Wagensberg, 2014). The careful design of 
experiments helps mitigate the possibility of the misinterpretation of data and is, 
consequently, something deserving of a great deal of attention. Reliable interpretation 
requires an understanding of the tools used during an empirical investigation, and this 
paper seeks to further characterise some of the uses (and missuses) of Green Fluorescent 
Protein (GFP), a tool that has had a profound impact upon the world of cell biology, 
within the context of drug delivery and gene therapy (Wahlfors et al., 2001). 
GFP and its fluorescent variants (Wachter, 2006) have been widely used since the 
discovery that a mutation of residue 65 (from serine to threonine), dramatically improved its 
spectral properties (Heim et al., 1995). GFP is commonly used as a protein “tag” that has 
been readily visualised in fixed or live cells either directly, using its intrinsic fluorescence i.e. 
“Brainbow” technology (Weissman and Pan, 2015), or indirectly using antibodies which have 
been identified via a secondary antibody conjugated to a fluorophore, radioisotope or enzyme 
(Nakamura et al., 2008). Here a further investigation into the usefulness of GFP within the 
context of drug delivery has been undertaken. Four questions pertinent to the use of GFP 
within various experimental situations have been posed: (1) Are molecules that regulate 
fusion to a specific compartment (i.e. Rab- or SNARE- GFP fusion proteins) a good choice of 
marker for that compartment (compartments described in figure 1)? (2) How reliable were 
GFP-marker overexpression experiments when used to define a given endocytic 
compartment?  (3) Can GST-GFP act as a fluid phase endocytic probe? (4) Was GFP 
fluorescence a robust indicator of (GFP) protein integrity?   
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Materials and Methods.  
Equipment: The orbital shaker, French Press, centrifuges (RC6 Plus) and microtiter plate 
reader (Microplate Photometer Multiskan FC) were from ThermoFischer, (Loughbourgh, 
UK). The mini-PROTEAN tetra cell, minitrans-blot, electrophoretic transfer cell and power 
supplies were from BioRad (Hemel Hempstead, UK). Fluorescence spectra were measured 
using a Fluoromax- 4 spectrofluorometer (Horiba Scientific, Middlesex, UK). Microscopic 
images were obtained using either: an Eclipse 90i microscope (Nikon UK Ltd., Surrey, UK) 
fitted with an Apo60 objective and a DS-Qi1Mc camera or an inverted Zeiss LSM880 fitted 
with a plan apochromat 63x (numerical aperture 1.40) oil emersion objective, (Carl Zeiss 
Ltd., Cambridge, UK) both with dedicated software. GST-GFP production and enrichment: 
The production and enrichment of glutathione-s-transferase (GST) fused in frame with GFP 
(GFP-GST) has been previously described (Pettit et al., 2014). In brief Escherichia coli 
MC1061 were transformed with pGFP-GST [GenBank JN232535.1] and were cultured in 
10mL of 2xYT (containing 25 µg/mL ampicillin) overnight at 37 oC shaking at 200 RPM. 
This culture was used to inoculate 1000 mL of 2xYT (containing 25 µg/mL ampicillin), 
which was left to incubate for 4 hours at 37 oC shaking at 200 rpm prior to the addition of 
IPTG to a final concentration of 1 mM. After an additional 4 h incubation, the bacteria were 
sedimented by centrifugation (6 000 xG for 10 min., at 4 oC). The bacterial pellet was 
suspended in 10 mL of PBS containing 10x EDTA free COmpleteTM protease inhibitor 
cocktail (Roche, Burgess Hill, UK). The bacterial suspension was then subject to lysis using a 
French Press set to 1500 psi to avoid the possibility of recombinant protein conformational 
relaxation (associated with detergent lysis). Sodium azide (final concentration of 0.02 % 
(w/v)) was then added to the preparation as a bacteriostatic. The GST-GFP protein was then 
enriched by affinity chromatography using glutathione-conjugated Sepharose 4b (GE 
Healthcare, Bucks, UK), in accordance with the manufacturer’s instructions and characterised 
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using gel electrophoresis, Coomassie staining and Western immunoblotting.  Spectroscopic 
and fluorescence analysis of GST-GFP. Previously spectrophotometric characterisation of 
GST-GFP determined that a wavelength of 484 nm was optimal for GFP excitation and was 
in agreement with the literature (Pettit et al., 2014). Consequently, GST-GFP emission spectra 
were recorded using an excitation wavelength of 484 nm using a Fluoromax- 4 
spectrofluorometer (Horiba Scientific, Middlesex, UK). GST-GFP stability and pull-down 
experiments: Enriched GST-GFP (500 μg) (in PBS) was placed in a sterile Eppendorf tube. 
Where a pull-down experiment was performed, glutathione conjugated Sepharose 4b beads 
(GE Healthcare, Bucks, UK) (200 µl bed volume in PBS) were added to the tube. The 
specified amount of protease was added to each tube and incubated at 37 oC for the specified 
time. When performing pull-down experiments the preparation was subject to sedimentation 
(1 min., at 14 000 rpm 4o C) and the emission spectra, or emission at 492 nm, for the 
supernatant was measured as stated. The pellet was suspended in 1 mL of PBS. Finally, 10 μl 
of this was then added to 1 mL of Laemmli buffer for analysis Western immunoblotting using 
a GFP specific polyclonal antibody (Cat No. CAB4211; Invitrogen, Paisley, UK). The 
emission spectra of the supernatants (after excitation at 484 nm) were recorded, prior to the 
addition of the Laemmli buffer. Cell culture, microscopy and “pulse-chase” experiments: 
Vero cells (ATCC number CCL-81), were cultured as previously described (Dyer et al., 
2015). Purified GST-GFP in PBS was filter sterilised using a 0.2 micron filter (Milipore Ltd, 
Hertfordshire, UK) and added to cultured cells at a concentration of 1 mg/mL in the presence 
of 200 µM Leupeptin (Sigma-Aldrich Company Ltd., Dorset, UK). This “pulse” of GST-GFP 
was added to complete cell culture media and incubated for 4 hours at 37 oC. The cells were 
then washed three times with fresh sterile PBS and returned to incubate in complete media for 
an additional 20h at 37oC in 5% (v/v) CO2. The cells were then washed 3 times in PBS and 
fixed with either cold methanol or formaldehyde (as noted) and as previously described (Dyer 
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et al., 2013; Dyer et al., 2015). Immunostaining was performed as previously described 
(Richardson et al., 2004; Richardson et al., 2008; Dyer et al., 2013; Dyer et al., 2015) using 
EEA1 (BD Bioscience,) LAMP1 or LAMP2 specific monoclonal antibodies (DHSB 
hybridoma bank, University of Iowa, USA) as previously described (Richardson et al., 2004; 
Richardson et al., 2008; Dyer et al., 2015). Over-expression experiments: were conducted as 
previously described (Richardson et al., 2004). Briefly, 5x105 Vero cells / well were used to 
seed a 6 well plate. To each well, complete media was added to a final volume of 1.5 mL and 
the plate placed in a humidified cell culture incubator (37 oC; 5% (v/v) CO2) overnight. Pulse-
chase and transfection experiments. Texas Red labelled (TxR)-wheat-germ agglutinin (WGA) 
(TxR-WGA) (Invitrogen, Paisley, UK), was used at a concentration of 10 µg/mL in complete 
media containing 200 µM leupeptin (Sigma Chemical Company, Dorset, UK).  Cells were 
incubated with TxR-WGA for 4 hours and then transfected using lipofection over 4 hours and 
incubated for a further 40 hours prior to fixation. Lipofection was performed using 
Lipofectamine 2000 (Invitrogen, Paisley, UK) as per the manufacturer’s instructions using 2.5 
µg of plasmid per well. The eGFP-Rab5 encoding plasmid has been previously described 
(Richardson et al., 2004; Roberts et al., 1999). Where there was no transfection cells were 
subject to a pulse (4 hours), washed 3 times with PBS and then incubated for a further 20 
hours in complete media prior to fixation. Sequence comparisons; were performed using the 
DNAStar software suite by Lasergene (Madison WI, USA). Protein sequences were obtained 
(http://www.uniprot.org) and analysed using the MegaAlign application (DNAStar by 
LASERGENE, Madison WI) deploying the Clustal-W algorithm. Protein sequence identities 
(and UniProt reference numbers) are given (table 1). 
 
  
 7 
Results. 
Sequence comparisons as an indicator of marker viability. When the primary protein 
sequences of the Rat Sarcoma (Ras)-related in brain (Rab)5 isoforms a, b and c were 
analysed, a very high level of sequence identity was evident (table 2, i.e. between 81.9 and 
87.4 %). Given the antigens used to generate the selection of antibodies to Rab5 documented 
(table 3), it was unlikely that the antibodies listed would be specific for a given isoform, given 
the identity (%) between the antigens used to raise them. The similarity between the various 
primary protein sequences of isoforms of the Rab6-subfamily (Rab6a, Rab6a’, Rab6b, Rab6c 
and Rab41) was also striking (table 4, i.e. between 98.6 – 61.3% sequence identity). Table 5 
describes the antigens used to raise selective commercially available antibodies and further 
emphasises the capacity for mislabelling specific isoforms of Rab6 using commercially 
available antibodies. Table 6 describes the levels of protein sequence similarity that result 
from comparing syntaxin7 and syntaxin12 (also called syntaxin13), which also demonstrated 
a high level of sequence identity (56.2%). 
Over-expressed GFP-fusion proteins as intracellular markers. In an effort to evaluate the 
compartmentalisation of transiently expressed eGFP-Rab5a in relation to an endocytosed 
probe (TxR-WGA), eGFP-Rab5a was expressed in Vero cells. EEA1 has been well 
documented as a Rab5 binding partner (Simonsen et al., 1998), which interacts with 
membrane inositol phosphates (Simonsen et al., 1998). Figure 2 (panels: (a) (anti-EEA1 
localisation), (b) (eGFP-Rab5a) and (c) (merge) show a considerable degree of co-
localisation, with specific examples of vesicles positive for both EEA1 and eGFP-Rab5a 
being denoted by arrows in the inset. These vesicles are of a size, distribution and 
morphology typical of Vero cells (Dyer et al., 2013; Richardson et al., 2008; Richardson et 
al., 2004). Figure 2 also shows the effect of probing cells expressing eGFP-Rab5a (panel d) 
with TxR-WGA (panels e). The expanded vesicular structures positive for both TxR-WGA 
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and eGFP-Rab5a (panel f) were profound. This phenotype has been associated with very high 
(~50 µg/mL) concentrations of WGA (Dyer et al., 2013) or the constitutively active, GTP 
locked Rab5 mutant, Rab5:Q79L (Barbieri et al., 1996). Figure 2 (panel g) shows cells that 
have been incubated with TxR-WGA after transient transfection with eGFP-Rab5:Q79L 
(panel i). The similarity in phenotype (i.e. expanded GFP positive vesicles) between eGFP-
Rab5a co-incubated with WGA (panel e) and the eGFP-Rab5:Q79L mutant (panel h) was 
striking. Figure 2 (panel i) shows the co-localisation of TxR-WGA and the overexpressed 
eGFP-Rab5:Q79L mutant. In the absence of the Rab5 transfection TxR-WGA (panel j) can be 
seen localising to a LAMP1 positive (late endocytic) compartment (panel l). Specific 
examples of vesicles positive for both TxR-WGA and LAMP1 have been denoted by arrows 
(inset).  
GFP fluorescence as a marker for protein integrity. Figure 3 (panel a) shows the emission 
spectra of GST-GFP over time and there was no readily quantifiable alteration in emission 
spectra over the 300min documented. The protease trypsin (~0.5units / 500µg GST-GFP) also 
had very little effect upon the emission spectra of GST-GFP over 300min (panel b), which 
was similar to the effect produced by adding proteinase k (10units / 500µg GST-GFP) (panel 
c). When the integrity of the protein GST-GFP was examined by Western immunoblotting, it 
was evident that at 5min, both trypsin (~0.5 units / 500µg GST-GFP) and proteinase k (10 
units / 500µg GST-GFP) had digested GST-GFP, whereas the negative control (no protease) 
was stable over 300min. A solution to this impasse i.e. using the spectral properties of GFP to 
monitor protein integrity, was found by using the GST portion of GST-GFP to bind to 
glutathione-conjugated Sepharose after protease treatment and, after washing away any non-
bound material, assaying for fluorescence emission at 492 nm (figure 3: panel e).  
The use of GFP as an endocytic probe. The utility of eGFP as a probe for endocytic capture 
(i.e. as cargo) was explored (figure 4). The late endocytic marker lysosome associated 
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membrane protein (LAMP)1 has been well-characterised and localises to late endosomes, 
endolysosomes and lysosomes (Chen et al., 1985). The anti-LAMP1 and anti-LAMP2 
antibodies required the fixation of cells in cold methanol for immunofluorescence work. After 
MeOH fixation, little GFP signal was evident (figure 4: panel a) despite the LAMP1 signal 
being readily detectable (panel b). After fixation using aldehyde, the signal from GST-GFP 
(panel d) was clearly coincident with that from TxR-bovine serum albumin (BSA) (panel e), 
which, at 24h, has been reported resident in a late endocytic compartment (panel f) 
(Richardson et al., 2008). The data describing the localisation of GST-GFP relative to TxR-
BSA (panels d, e and f) appears to be substantiated by those describing the location of GST-
GFP (panel g) relative to early endosomal marker EEA1 (panel h) after 24h. Here there 
appears to be some signal from GFP, however, there was some, but not exclusive localisation 
between GFP-GST and EEA1. Figure 4 (panel j) highlights another problem with using GFP-
GST as a probe. Here, aldehyde fixed cells co-labelled with TxR-WGA, display a marked 
lack of GFP signal (panel j) relative to a robust TxR-WGA signal (panel k) when examined 
using an LSM880. This made assessing the level of co-localisation very difficult (panel l). 
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Discussion. 
When interpreting data from single cell assays, a variety of assumptions are often made with 
regard to the nature of a GFP “tag". The first is that if the GFP molecule has been degraded, 
then fluorescence output would be reduced accordingly. The second is that a GFP tagged 
molecule will behave in a way that was representative of the analogue it was being used to 
mimic. Finally, there remains an assumption that because a molecule has been documented in 
a specific location, that location is where the molecule in question must function. This final 
observation is a fallacy, as a molecule will be observed where there is a large pool of the 
molecule, even a reservoir, which may not necessarily be the place where the molecule 
functions. However, unpacking this assumption is beyond the scope of this paper. The first 
and second assumptions are challenged herein by addressing the questions stated in the 
introduction: 
Are molecules that regulate fusion to a specific compartment (i.e. Rab- or SNARE-GFP 
fusions) a good choice of marker for that compartment? The various Rab5 isoforms 
documented (table 2) generally have the same intracellular distribution (i.e. to early endocytic 
compartments) (Chen et al., 2014). Consequently, the issue of misidentifying a Rab5 isoform 
would not present a huge problem in terms of mislabelling a specific intracellular 
compartment. Most intracellular markers occupy more than one intracellular compartment, a 
specific example being the transferrin receptor, which is often used as a marker for recycling 
endosomes (i.e. a Rab11 enriched compartment) (Richardson, 2010). This receptor cycles 
through early and recycling endosomes en route to the plasma membrane, and back to the 
early endosome after internalisation.  The Rab6 subfamily of proteins is a little more diverse 
than the various isoforms of Rab5, regulating fusion through the Golgi network (Liu and 
Storrie, 2015). However, specific isoforms have demonstrated tissue specific expression. 
Rab6b has been found mainly in neuronal cells (Opdam et al., 2000), and Rab6c has been 
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documented in: brain, testes, prostate and breast tissue (Young et al., 2010). Functional 
variance between Rab6a and Rab6a’ has been reported during the retrograde transport of ricin 
(Utskarpen et al., 2006; Liu and Storrie, 2015). Consequently, the result of mislabelling a 
particular Rab6 isoform, or expressing it in an inappropriate cell type, may be a little more 
misleading. The result of misidentifying syntaxin proteins, such as 7 and 13, may be more 
drastic as misidentifying them would, in all likelihood, lead to the generation of false 
positives or negative conclusions in relation to subcellular distribution or trafficking. 
Syntaxin13 typically catalyses vesicle fusion events between early endocytic structures, such 
as early endosomes (McBride et al., 1999). Syntaxin7, also a t-soluble N-ethylmaleimide 
sensitive factor attachment protein receptor (SNARE) heavy chain, catalyses both heterotypic 
and homotypic fusion to late endosomes (Mullock et al., 2000; Pryor et al., 2004). The 
similarity between the protein sequences of all of these molecules makes the generation of 
specific polyclonal antibodies challenging.  The consequences of misidentifying syntaxin7 
and 13 have been reported (Mullock et al., 2000). Here additional immunodepletive steps to 
removed cross-reactive antibodies were taken to ensure antibody specificity (Mullock et al., 
2000). 
Equivalently, monoclonal antibodies may be used to identify molecules that act as 
compartmental “doorkeepers”, responsible for regulating fusion to, and consequently the 
identity of a specific intracellular compartment (Dyer et al., 2013). This is considerably more 
time consuming and expensive than generating polyclonal antisera. Given the challenges and 
expense associated with generating polyclonal or monoclonal antibodies, specific for proteins 
with such a high degree of similarity, it may be easier and more accurate to express these 
molecules as GFP-fusion proteins. Rather than immunodetecting Rab6a and Rab6a’ after 
siRNA knockdown, qPCR has been used (Utskarpen et al., 2006). This approach has many 
limitations with regard to examining the trafficking of endocytosed cargo within the context 
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of single-cell assays, but is certainly worth considering when using a population based cell 
assay. When considering the utility of a specific marker, the general and the specific need to 
be considered separately, given that there are nearly always exceptions to any rules of thumb. 
An example might be the distribution of syntaxin6 in melanocytes. In B16F10 cells syntaxin6 
has been documented to localise to late endosomes (Wade et al., 2001). However, this 
localisation has been reported to be melanocyte specific and would not be expected in more 
generic epithelial cells. 
How reliable were GFP-marker overexpression experiments when used to define a given 
endocytic compartment?  Over a 24h timeframe, a pulse of WGA has been documented in a 
late endocytic compartment, which would normally contain markers including LAMP1 (or 2), 
lysosomal hydrolases (such as cathepsin D), or even well-characterised probes such as bovine 
serum albumin (BSA) or BSA-colloidal gold, subject to endolysosomal translocation 
(Mullock et al., 2000). The dose of WGA (typically from 5-50 µg/mL) may also impact upon 
the morphology of late-endocytic compartments, however, here the dose of TxR-WGA was 
kept constant at 10 µg/mL as previously this had given a robust signal at a minimal 
concentration (of WGA) (Dyer et al., 2013). Observing a profound co-localisation between 
overexpressed eGFP-Rab5a and WGA at 48h post-transfection was unexpected (figure 2: 
panels d-f), as previously, at this time, the internalised WGA and Rab5 might be expected to 
occupy late and early endocytic compartments respectively (Dyer et al., 2013). This 
confusion was further underscored by the localisation of eGFP-Rab5 to an early endosomal 
antigen (EEA)1 positive compartment (figure 2: panels a-c). Moreover, after 24h, WGA was 
recorded in a LAMP positive set of vesicular structures (figure 2: panels j, k and l). These 
data are further contradicted by previously published data reporting eGFP-Rab5a localising to 
EEA1positive structures that are typically early endocytic (i.e. on early endosomes) 
(Simonsen et al., 1998; Roberts et al., 1999), yet WGA, when chased into eGFP-Rab5a 
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overexpressing cells can be seen in dramatically expanded Rab5 positive structures (figure 2: 
panels d-f). Given that EEA1 not only interacts with the Rab protein, as an effector, but also 
inositol phosphates on the early endosomal membrane (Simonsen et al., 1998), it is unlikely 
(although still possible), that the EEA1 signal was simply being redistributed by the 
overexpressed eGFP-Rab5a. Further, there are examples of Rab5a overexpression being 
separate and discreet from late endocytic markers (Dyer et al., 2013). Confusion was 
compounded by the data describing the eGFP-Rab5:Q79L mutant, a GTP locked 
constitutively active mutant of Rab5 (Barbieri et al., 1996). This has been documented to 
cause expanded vesicles that have often lost their compartmental identity as the “doorkeeper” 
or Rab protein regulating fusion becomes hyperactive (Barbieri et al., 1996). It is possible 
that the cells documented (panels d, e and f) were expressing a lot of Rab5a, which gave rise 
to a phenotype similar to that of the Rab5:Q79L mutant. Equivalently the phenotype observed 
may be due to an interaction between the WGA and the effects of Rab5 overexpression. This 
may not impact upon the assumption that the GFP tagged protein will behave in a similar way 
to its wild type analogue as this variance in phenotype may not be due to any alteration in 
protein function, but is instead due to there being much more Rab5 than would normally be 
found in a healthy cell.  It is important to note that when using these tools, in these specific 
circumstances, a degree of compartment identity has been lost. Care should also be exercised 
when using algorithms to quantitate the degree of co-localisation. Commonly used methods to 
quantify co-localisation include the use of Pearson's correlation coefficient (adapted by 
Manders) that are quite subjective though maybe useful if applied appropriately (Richardson 
et al., 2004; Dunn et al., 2011). Their usefulness is also defined by the definition of co-
localisation being employed and the inferences being made. If these experiments are an 
attempt to discover the function of a specific protein and are attempting to resolve individual 
molecules, they may also be limited by the resolution of even super-resolution techniques 
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(Dunn et al., 2011). Figure 2 (panels j, k and l) clearly show late endocytic markers 
partitioned into microdomains, contained within the same vesicle. However, as there are 
varying degrees of co-localisation at the level of the pixel, as opposed to the vesicle, false 
negatives may result. 
Was GFP fluorescence a robust indicator of (GFP) protein integrity? GFP stability 
in the presence of proteases has been reported to be high (Aoki et al., 2008). Here the authors 
used a binding assay similar to the “pulldown” assay described here (figure 3: panel e) to 
monitor protein integrity (Aoki et al., 2008). Figure 3 (panels a-d) documents the effects of 
both proteinase k and trypsin upon the fluorescence of eGFP. Previously GST-GFP was 
sequenced using mass spectrometry, and determined both its absorption and emission spectra 
in relation to eGFP determined (Pettit et al., 2014). GST-GFP was found to exhibit maximum 
excitation when stimulated at 484nm with an emission peak at 492nm. This was in contrast to 
eGFP, which displays a maximum excitation peak at 488nm and an emission peak at 509nm 
(Pollock and Heim, 1999). When either protease was used to digest GST-GFP (confirmed by 
Western immunoblotting (figure 3: panel d), the fluorescence spectra remained unaltered after 
digestion (figure 3: panels a-c). The simplest explanation for the apparent disconnect between 
fluorescence and GST-GFP molecular weight, was that the fluorophore located within the 
eGFP beta-barrel spanning helix remained partially intact after digestion. This was 
unexpected. However, practically, this particular phenomenon was relatively easy to 
circumvent if the GFP molecule was designed to contain an affinity “tag” to aid enrichment. 
An example might be a 6-histidine tag or a GST “tag” as documented here (figure 3: panel e).  
Can GST-GFP act as a fluid phase endocytic probe? Given the well-characterised 
effects of pH upon eGFP’s fluorescent properties (Roberts et al., 2016) it was not surprising 
to note the aberrant compartmentalisation of GST-GFP post-endocytic capture. Very recently, 
the problem of eGFP’s instability at low pH has been addressed using tandem dimer GFP 
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variant (Ishil et al., 2007; Roberts et al., 2016), however the problem of lysosomal proteases 
and methanol fixation remain. For optimal fluorescence yield, eGFP has been reported to 
require aldehyde fixation rather than fixation in cold methanol (Dyer et al., 2013). 
Consequently, the combination of low pH, methanol fixation and the presence of lysosomal 
proteases would not predispose eGFP as a robust fluid phase endolysosomal marker. This was 
underscored in figure 4. Consequently, it may be more advantageous to use a transiently or 
stably expressed, well-characterised fluorescent protein fused to the cytosolic termini of a 
lysosomal trans-membrane protein as a marker such as LAMP1-RFP (Sherer et al., 2003). 
Finally, the choice of marker should also be dictated by application. Is it essential to know 
how many molecules are in a given compartment for optimal therapeutic effect? If so then 
perhaps a radiolabel is a more useful “tag” than any fluorescent molecule due to the ease of 
quantification. Previously, we have published a study quantifying the modulation of 
subcellular distribution mediated by of a series of well-defined radiolabelled 
poly(amidoamine) polymers after their administration in vivo (Richardson et al., 2010). When 
the possibility of optimising a dose to minimise non-specific side effects is considered, the 
use of radioprobes remains attractive. That said radioprobes have limited use relative to 
fluorescent probes within the context of a single cell assay, which is also very useful for early 
stage evaluation of advanced drug delivery system function and subcellular distribution (Seib, 
et al., 2006; Richardson et al., 2008). 
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Conclusion. 
 GFP remains a useful tool to evaluate subcellular trafficking, providing the limitations 
associated with its biochemistry are understood. This is true of any marker used to define a 
compartment. GFP’s stability and fluorescent properties are not intimately connected, 
consequently care needs to be taken when designing experiments that might expose GFP to 
proteases either during in vitro cell free assays or in a cell based assay.  These observations 
highlight some of the pitfalls working with eGFP. More generally, they also highlight the 
need for carefully designed experiments, a need to understand and characterise the tools you 
are using and the use of multiple controls in order to interrupt the data they produce in a 
useful and meaningful way. Is seeing believing? No, though clearly fluorescent proteins are 
extremely useful tools though as ever, context is everything. 
  
 17 
References.  
Aoki T., Tsuchida S., Yahara T., Hamaue N. (2008), Novel assays for proteases using green 
fluorescent protein-tagged substrate immobilized on a membrane disk. Anal. Biochem., 
378(2):132-7. doi: 10.1016/j.ab.2008.04.022. 
  
Barbieri M. A., Li G., Mayorga L. S., Stahl P. D. (1996) Characterization of Rab5:Q79L-
Stimulated Endosome Fusion, Archives of Biochemistry and Biophysics, 326 (1):64-72, doi: 
10.1006/abbi.1996.0047. 
 
Chen J.W., Murphy T.L., Willingham M.C., Pastan I., August J.T. (1985), Identification of 
two lysosomal membrane glycoproteins, J. Cell Biol., 101(1):85-95. 
 
Chen P.I., Schauer K., Kong C., Harding A.R., Goud B., and Stahl P.D. (2014), Rab5 
isoforms orchestrate a "division of labor" in the endocytic network; Rab5C modulates Rac-
mediated cell motility, PLoS One, 9(2):e90384. doi: 10.1371/journal.pone.0090384. 
 
Dyer P.D., Shepherd T.R., Gollings A.S., Shorter S.A., Gorringe-Pattrick M.A., Tang C.K., 
Cattoz B.N., Baillie L., Griffiths P.C., Richardson S.C. (2015), Disarmed anthrax toxin 
delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity. J. 
Control Release, 220(Pt A):316-28. doi: 10.1016/j.jconrel.2015.10.054. 
 
Dyer P.D., Kotha A.K., Pettit M.W., Richardson S.C. (2013), Imaging select mammalian 
organelles using fluorescent microscopy: application to drug delivery, Methods Mol Biol. 
991:195-209. doi: 10.1007/978-1-62703-336-7_19. 
 
Dunn K. W., Kamocka M. M. and McDonald J. H. (2011), A practical guide to evaluating 
colocalization in biological microscopy, Am. J. Physiol. Cell Physiol., 300(4): C723–C742, 
doi:  10.1152/ajpcell.00462.2010. 
 
Heim R., Cubitt A. B. and Tsien R. Y. (1995), Improved green fluorescence, Nature, 373 
(6516); 663-4. doi:10.1038/373663b0. 
 
Ishii M., Kunimura J.S., Jeng H.T., Penna T.C., Cholewa O. (2007), Evaluation of the pH- 
and thermal stability of the recombinant green fluorescent protein (GFP) in the presence of 
sodium chloride. Appl Biochem Biotechnol., 137-140(1-12):555-71. doi: 10.1007/s12010-
007-9079-6. 
 
Liu S., and Storrie B. (2015), How Do Rab Proteins Determine Golgi Structure? Int. Rev. Cell 
Mol. Biol., 315:1–22. doi:10.1016/bs.ircmb.2014.12.002. 
 
McBride, H.M., Rybin, V., Murphy, C., Giner, A., Teasdale, R., and Zerial, M. (1999), 
Oligomeric complexes link Rab5 effectors with NSF and drive membrane fusion via 
interactions between EEA1 and syntaxin 13. Cell, 98: 377–386.  
 
Mullock B. M., Smith C. W., Ihrke G., Bright N. A., Lindsay M., Parkinson E. J., Brooks D. 
A., Parton R. G., James D. E., Luzio J. P., Piper R. C. (2000), Syntaxin 7 Is Localized to Late 
Endosome Compartments, Associates with Vamp 8, and Is Required for Late Endosome–
Lysosome Fusion. Mol. Biol. Cell.,  11: 3137–3153. 
 
 18 
Nakamura K.C., Kameda H., Koshimizu Y., Yanagawa Y., Kaneko T. (2014), Production and 
histological application of affinity-purified antibodies to heat-denatured green fluorescent 
protein, J. Histochem Cytochem., 56(7):647-57. doi: 10.1369/jhc.2008.950915. 
 
Opdam F.J., Echard A., Croes H.J., van den Hurk J.A., van de Vorstenbosch R.A., Ginsel 
L.A., Goud B., Fransen J.A. (2000), The small GTPase Rab6B, a novel Rab6 subfamily 
member, is cell-type specifically expressed and localised to the Golgi apparatus. J. Cell Sci. 
113(15):2725–2735. 
 
Pettit M.W., Dyer P.D., Mitchell J.C., Griffiths P.C., Alexander B., Cattoz B., Heenan R.K., 
King S.M., Schweins R., Pullen F., Wicks S.R., Richardson SC. (2014), Construction and 
physiochemical characterisation of a multi-composite, potential oral vaccine delivery system 
(VDS), Int. J. Pharm., 468(1-2): 264-71. doi: 10.1016/j.ijpharm.2014.03.046. 
 
Pollok B. A. and Heim R. (1999), Using GFP in FRET-based applications, Trends in Cell 
Biology, 9(2):57-60. 
 
Pryor P. R., Mullock B. M., Bright N A., Lindsay M. R., Gray S. R.,   Richardson S. C. W., 
Stewart A., James D. E., Piper R. C., & Luzio J. P. (2004), Combinatorial SNARE complexes 
with VAMP7 or VAMP8 define different late endocytic fusion events, EMBO reports, 
5(6):590-595. 
 
Richardson S. C. W. (2010), Tracking Intracellular Polymer Localization Via Fluorescence 
Microscopy, in: Organelle-Speci c Pharmaceutical Nanotechnology, Edited by Volkmar 
Weissig and Gerard G. M. D’Souza   P117-193. 
 
Richardson S.C., Wallom K.L., Ferguson E.L., Deacon S.P., Davies M.W., Powell A.J., Piper 
R.C., Duncan R. (2008), The use of fluorescence microscopy to define polymer localisation to 
the late endocytic compartments in cells that are targets for drug delivery, J. Control. Release, 
127(1):1-11. doi: 10.1016/j.jconrel.2007.12.015.  
 
Richardson S.C., Pattrick N.G., Lavignac N., Ferruti P., Duncan R. (2010) Intracellular fate of 
bioresponsive poly(amidoamine)s in vitro and in vivo. J. Control. Release, 142(1):78-88. doi: 
10.1016/j.jconrel.2009.09.025. 
 
Richardson S.C., Winistorfer S.C., Poupon V., Luzio J.P., Piper R.C. (2004), Mammalian late 
vacuole protein sorting orthologues participate in early endosomal fusion and interact with the 
cytoskeleton, Mol Biol Cell., 15(3):1197-210. 
 
Roberts R. L., Barbieri M. A., Pryse K.M., Chua M., Morisaki J.H., Stahl P.D. (1999) 
Endosome fusion in living cells overexpressing GFP-rab5. J. Cell Sci., 112 (21): 3667-75. 
 
Roberts T.M., Rudolf F., Meyer A., Pellaux R., Whitehead E., Panke S., Held M. (2016), 
Identification and Characterisation of a pH-stable GFP, Scientific Reports 6, Article number: 
28166, doi:10.1038/srep28166. 
 
Seib P. F., Jones A., Duncan R. (2007), Comparison of the endocytic properties of linear and 
branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells, J. Controlled 
Release, 117(3):291-300, DOI: 10.1016/j.jconrel.2006.10.020. 
 
 19 
Simonsen A., Lippe R., Christoforidis S., Gaullier J-M., Brech A., Callaghan J., Toh B-H., 
Murphy C., Zerial M. & Stenmark H. (1998) EEA1 links PI(3)K function to Rab5 regulation 
of endosome fusion. Nature 394, 494-498. doi:10.1038/28879. 
 
Sherer N.M., Lehmann M.J., Jimenez-Soto L.F., Ingmundson A., Horner S.M., Cicchetti G., 
Allen P.G., Pypaert M., Cunningham J.M., Mothes W. (2003) Visualization of retroviral 
replication in living cells reveals budding into multivesicular bodies, Traffic, 4(11):785-801 
 
Utskarpen A., Slagsvold H. H., Iversen T-G., Walchli S., and Sandvig K., (2006) Transport of 
Ricin from Endosomes to the Golgi Apparatus is Regulated by Rab6A and Rab6A’. Traffic, 
7: 663–672 doi: 10.1111/j.1600-0854.2006.00418.x. 
 
Wachter R.M., (2006), The family of GFP-like proteins: structure, function, photophysics and 
biosensor applications. Introduction and perspective, Photochem Photobiol. 82(2): 339-44. 
 
Wade N., Bryant N. J., Connolly L. M.,, Simpson R. J., Luzio J. P., Piper R. C., and James D. 
E. (2001) Syntaxin 7 Complexes with Mouse Vps10p Tail Interactor 1b, Syntaxin 6, Vesicle-
associated Membrane Protein (VAMP)8, and VAMP7 in B16 Melanoma Cells. JBC, 
276(23):19820–19827, DOI 10.1074/jbc.M010838200. 
 
Wagensberg J. (2014) On the Existence and Uniqueness of the Scientific Method, Biol 
Theory, 9(3): 331–346, doi: 10.1007/s13752-014-0166-y. 
 
Wahlfors J., Loimas S., Pasanen T., Hakkarainen T. (2001), Green fluorescent protein (GFP) 
fusion constructs in gene therapy research, Histochem Cell Biol., 115(1): 59-65. 
 
Weissman T.A., Pan Y.A. (2008), Brainbow: new resources and emerging biological 
applications for multicolor genetic labeling and analysis. Genetics. 199(2) :293-306, doi: 
10.1534/genetics.114.172510. 
 
Young J, Ménétrey J, Goud B. (2010), RAB6C is a retrogene that encodes a centrosomal 
protein involved in cell cycle progression. J. Mol Biol., 397(1): 69–88. 
  
 20 
Acknowledgements. 
All of the authors, particularly SCWR would like to acknowledge Ruth Duncan’s mentoring 
over the years in both CPT and within the IDS laboratory. SAS, MG-P, EC-Y and MWP 
would like to thank the Faculty of Engineering and Science, University of Greenwich for 
funding their PhD studies. 
  
 21 
Tables. 
Table 1: Protein sequence identity. Adapted from: Echard et al., 2001, Liu and Storrie 2015 and the 
Uniprot (www.uniprot.org) and Abcam (www.abcam.com) websites.  
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Table 2: Rab5 family members and their level of protein sequence identity. Rab5a isoform 2 is identical to isoform 1 with the exception of 
the deletion of “AAFLTQTVCLDDTT” in isoform 2. Rab5b isoform 2 is identical to isoform 1 with the exception of the deletion of 
“TFARAKTWVKELQRQASPSIVIALAGNKADLANKRMVEYEE” in isoform 2. Rab5c isoform 2 contains an additional N-terminal 
“MELSWRSPSPLSASLHSTSPHPHALWTTTAGRA”. In each instance isoform 1 has been used in the above. 
 
  
 
Table 3: Antigen similarity (identity (%) for select Rab5-specific antibodies (listed in table 1) 
 
 
Table 4: Rab6-subfamily members and their level of protein sequence identity 
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Table 5: Antigen similarity (identity (%) for Select Rab6 subfamily-specific antibodies 
 
  
 
 
Table 6: Similarity (identity (%)) between the primary structure of syntaxin7 and 12 (13)  
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Figures. 
Figure 1: Cartoon Depicting Select Markers Defining Endocytosis and Exocytosis. This cartoon depicts both the endocytic and exocytic 
trafficking pathways and some of the more commonly used markers to identify organelles therein. Summarised are the various probes that 
have been documented within specific compartments over time. Adapted from (Mullock et al., 2001; Richardson et al., 2008; Dyer et al., 
2013) 
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Figure 2: Aberrant eGFP-Rab5a compartmentalisation and vesicular morphology. Here (panels a, b & c), eGFP-Rab5a transiently 
transfected Vero cells were aldehyde fixed and immunolabelled with a monoclonal anti-EEA primary antibody and a TxR conjugated- anti 
mouse secondary antibody 48 hours after transfection using Lipofectamine 2000. Panel (a) shows the detection of an anti-EEA1 antibody, 
panel (b) shows the eGFP signal and panel (c) is a merge of the red and green channel. Co-localisation was evident and exemplified by 
arrows in the panels inset (panels a & b). Panels (d, e and f) record Vero cells also transiently transfected with eGFP-Rab5a that have also 
been exposed to TxR-WGA (10µg/mL for 4h at 37oC) and then chased for an additional 40h in complete media containing 200µM leupeptin 
also at 37oC. Panel (d) depicts the red channel, panel (e) documents the green channel and panel (f) is a merge of the red and green channels. 
Panels (g, h & i) show Vero cells transiently transfected with eGFP-Rab5:Q79L and fed TxR-WGA as above after 48h. Panels (j, k and l) 
depict Vero cells incubated with TxR-WGA as above, and fixed in cold methanol before being immunolabelled with monoclonal primary 
antibody specific for LAMP2. This antibody was then detected using a mouse–IgG specific AlexaFluor 488 conjugated secondary. Imaging 
was on a Zeiss LSM880.The size bar is equal to approximately 5 microns. 
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Figure 3: GFP Fluorescence and Stability in Relation to Protease Activity. Panel (a) documents the emission spectra of GST-GFP over 300 
min in PBS after excitation at 484nm. The emission spectra of GST-GFP after exposure to ~0.5 units / 500µg GST-GFP of trypsin is shown 
(panel b) also over a similar time frame. Panel (c) documents the emission spectra of GST-GFP after exposure to 10units / 500µg GST-GFP 
of proteinase k. Panel (d) explores the molecular weight of GST-GFP by Western immunoblotting after 300min in PBS, 5 and 10min 
exposure to either 10units / 500µg GST-GFP, of proteinase k or ~0.5 units / 500µg GST-GFP of trypsin. Panel (e) documents the ability to 
affinity isolate GST-GFP from a protease digestion and then use the GFP portion of GST-GFP to quantify protein integrity using GST-GFP’s 
emission at 492nm. 
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Figure 4: Use of GFP as an endocytic probe. Panels (a, b and c) document Vero cells fixed in methanol, 20h after a 4h pulse of GST-GFP 
in complete media with 200µM leupeptin. These cells were then immunostained using an anti-LAMP1 monoclonal antibody and a mouse 
IgG specific – TxR conjugated secondary antibody. Aldehyde fixed cells (panels d, e and f) fixed 20h after a 4h pulse with both GST-GFP 
and TxR-BSA were documented. The localisation of a GST-GFP pulsed (as described above) to a compartment labelled with a primary 
monoclonal antibody specific for EEA1 and a mouse specific TxR labelled- secondary is documented (panel: (g) (GST-GFP), (h) (anti-
EEA1) and (i) (merge). These micrographs were acquired using a Nikon Ti-20 microscope. The localisation of GST-GFP, pulsed and chased 
as before is documented (panels j, k and l). The signal from GST-GFP (panel j) is very weak; where as the signal from a pulse of TxR-WGA 
(panel k) is robust. A merge (panels j and k) is shown and these images were acquired using a Zeiss LSM880. The size bar represents 
approximately 5 microns. 
 
